Matches in Wikidata for { <http://www.wikidata.org/entity/Q85030923> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q85030923 description "artículu científicu espublizáu n'ochobre de 2011" @default.
- Q85030923 description "scientific article published on 01 October 2011" @default.
- Q85030923 description "wetenschappelijk artikel" @default.
- Q85030923 description "наукова стаття, опублікована в жовтні 2011" @default.
- Q85030923 name "Onset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect?" @default.
- Q85030923 name "Onset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect?" @default.
- Q85030923 type Item @default.
- Q85030923 label "Onset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect?" @default.
- Q85030923 label "Onset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect?" @default.
- Q85030923 prefLabel "Onset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect?" @default.
- Q85030923 prefLabel "Onset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect?" @default.
- Q85030923 P1433 Q85030923-3808A87A-9918-40BC-B2D9-7F4097A35F4F @default.
- Q85030923 P1476 Q85030923-75F9F5BF-DD5C-4515-9750-32B7D0C34D7C @default.
- Q85030923 P2093 Q85030923-20957BB9-736E-449E-B735-6E607A1CB54E @default.
- Q85030923 P2093 Q85030923-68F42F3C-450E-416D-9129-B1D6D18C88CF @default.
- Q85030923 P2093 Q85030923-93D2F3C6-421E-4434-AB58-F1F4E8E77090 @default.
- Q85030923 P2093 Q85030923-D1799E2C-475E-4A8C-9251-D7A7A18FB426 @default.
- Q85030923 P2093 Q85030923-F5D47252-98FE-45DB-B242-C389DA7D4819 @default.
- Q85030923 P304 Q85030923-48523E7A-E87B-4E5A-8178-D6325D3B179C @default.
- Q85030923 P31 Q85030923-973F1AA1-738B-4FA2-9EED-3FED8055AE66 @default.
- Q85030923 P356 Q85030923-BC9CC6EF-BDAD-41AE-8B38-C69E422A28A5 @default.
- Q85030923 P407 Q85030923-5654BA5E-9566-418D-A357-F112EAED7AC8 @default.
- Q85030923 P433 Q85030923-16BD862C-6A3F-4BB3-9E96-A5B05F0DD884 @default.
- Q85030923 P478 Q85030923-6B01D2DA-12B8-454E-9269-EFBC4B5DB65F @default.
- Q85030923 P577 Q85030923-0911F6E4-F545-4499-8FD8-B24C8B5542DB @default.
- Q85030923 P698 Q85030923-90C9E46E-4336-4A97-A2B1-937612CB82C1 @default.
- Q85030923 P921 Q85030923-34C08F6F-59E1-4EC6-A421-96FE33090AE2 @default.
- Q85030923 P921 Q85030923-544B4BF0-EDE8-40CC-A9A0-E04BE6EBC971 @default.
- Q85030923 P356 JRHEUM.110170 @default.
- Q85030923 P698 21965707 @default.
- Q85030923 P1433 Q7743623 @default.
- Q85030923 P1476 "Onset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect?" @default.
- Q85030923 P2093 "Bernard Delbosc" @default.
- Q85030923 P2093 "Clément Prati" @default.
- Q85030923 P2093 "Daniel Wendling" @default.
- Q85030923 P2093 "Emmanuelle Dernis" @default.
- Q85030923 P2093 "Eric Frisch" @default.
- Q85030923 P304 "2284" @default.
- Q85030923 P31 Q13442814 @default.
- Q85030923 P356 "10.3899/JRHEUM.110170" @default.
- Q85030923 P407 Q1860 @default.
- Q85030923 P433 "10" @default.
- Q85030923 P478 "38" @default.
- Q85030923 P577 "2011-10-01T00:00:00Z" @default.
- Q85030923 P698 "21965707" @default.
- Q85030923 P921 Q3041498 @default.
- Q85030923 P921 Q425154 @default.